Search
  • Valis Bioscience
    • Nov 12, 2019

Valis co-founder speaks at KRIYA Conference

Valis Co-founder and CSO Dr. Christian Yavorsky spoke last weekend at the Kriya Conference in Northern California. Alongside Dr. Kelley O'Donnell, a researcher and practitioner at NYU, Dr. Yavorsky presented on the standardization of measurement outcomes in ketamine treatment.


Dr. Yavorky's extensive experience in measurement in rapid-acting depressants resulted in a well received presentation and several discussions which may lead to future Valis announcements.


More information regarding the event and topics covered can be found below.

https://www.kriyainstitute.com/schedule-2019/Christian Yavorsky

Recent Posts

See All

Last week Valis CEO Ivan Goldensohn attended the American College of Neuropsychopharmacology meeting in Orlando, Florida. The ACNP Meeting (more info at https://acnp.org/) is an invite-only annual mee

Valis Bioscience CEO Ivan Goldensohn attended the 10th annual CNS Summit in Boca Raton in late October. A long-time supporter of CNS Summit, Valis is excited to continue supporting CNS Summit and it's